




<rss xmlns:a10="http://www.w3.org/2005/Atom" version="2.0">
    <channel>
        <title>Arrhythmias and Clinical EP</title>
        <link>http://www.acc.org/Feed?clinicalTopicID=8bf30cda-f1ad-4ac5-aba0-91e57241c655</link>
        <description>Clinical Topic Feed: Arrhythmias and Clinical EP</description>
        <language>en</language>

        

                <item>
                    <title>State-of-the-Art Review Provides Practical Guidance on Treating Athletes With Arrhythmias</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/08/17/20/17/State-of-the-Art-Review</link>                    <description>A recent State-of-the-Art Review published in JACC: Clinical Electrophysiology introduces &quot;sports electrophysiology&quot; as an emerging area within sports cardiology and offers practical guidance for electrophysiologists and cardiovascular clinicians caring for athletic patients with arrhythmias.</description>
                    <pubdate>1787077560000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>New Clinical Performance, Quality Measures Define Standards For Managing AFib</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/08/17/20/17/New-Clinical-Performance-Quality-Measures-Define-Standards-For-Managing-AFib</link>                    <description>New 2026 AHA/ACC Clinical Performance and Quality Measures for Patients With Atrial Fibrillation (AFib) provide an updated framework to help improve the quality, consistency and equity of AFib care. Developed in collaboration with the American College of Clinical Pharmacy and the Heart Rhythm Society, the document translates the strongest Class 1 and Class 3 recommendations from the 2023 ACC/AHA AFib Guideline into measurable clinical practice standards. Read the full document in JACC.</description>
                    <pubdate>1786998000000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>2026 AHA/ACC Clinical Performance and Quality Measures for Patients With Atrial Fibrillation</title>
<link>https://www.jacc.org/doi/10.1016/j.jacc.2026.05.032</link>                    <description></description>
                    <pubdate>1786989600000</pubdate>
                    <category>Guidelines</category>
                </item>
                <item>
                    <title>AI-Enabled Clinician: Best Practices of Wearables in Cardiovascular Care</title>
<link>/Latest-in-Cardiology/Articles/2026/08/12/20/15/ai-enabled-clinician-13aug2026</link>                    <description>In this episode, Drs. Ami Bhatt, Rupal O&#226;€™Quinn, and Leon Ptaszek delve into the role of consumer wearables in cardiovascular care.</description>
                    <pubdate>1786636800000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>COMBINE-AF: Extracranial Bleeding Common With OAC in AFib Treatment</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/08/10/15/19/COMBINE-AF</link>                    <description>Clinically relevant extracranial bleeding affected approximately one in four patients receiving oral anticoagulation (OAC) for atrial fibrillation (AFib) over two years, potentially providing a more comprehensive measure of bleeding burden than major bleeding alone, according to a recent COMBINE-AF analysis published in Circulation.</description>
                    <pubdate>1786546740000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>MERCURI-2: Dapagliflozin Before Cardiac Surgery Lowers Postoperative AKI Risk</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/08/10/15/19/MERCURI-2</link>                    <description>Starting dapagliflozin one day before elective cardiac surgery reduced the incidence of postoperative acute kidney injury (AKI) during the first seven days after surgery, according to results from the double-blind, placebo-controlled MERCURI-2 trial published July 30 in JAMA.</description>
                    <pubdate>1786471800000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>ICECAP: Increasing Duration of Therapeutic Hypothermia After OHCA</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/08/10/15/19/ICECAP</link>                    <description>Increasing cooling duration in comatose survivors of out-of-hospital cardiac arrest (OHCA) being treated with therapeutic hypothermia did not improve neurological outcomes, according to findings from the multicenter, randomized ICECAP trial published in JAMA.</description>
                    <pubdate>1786449360000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>High Pediatric Ablation Success Regardless of Center and Operator Volume | NCDR Study</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/08/10/15/19/High-Pediatric-Ablation-Success</link>                    <description>Acute ablation success in pediatric patients was high across a range of center and operator volumes, with high-volume sites demonstrating the greatest likelihood of success for complex substrates, according to a recent study published in JACC: Advances.</description>
                    <pubdate>1786386480000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Can Plasma Infrared Molecular Fingerprinting Stratify Residual Risk in Patients With CAD?</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/08/03/10/06/Can-Plasma-Infrared-Molecular-Fingerprinting</link>                    <description>Plasma infrared molecular fingerprinting (IMF) is able to stratify residual mortality risk in patients with coronary artery disease (CAD), outperforming guideline-recommended SMART2 scores and capturing clonal haematopoiesis of indeterminate potential (CHIP)-associated biology without the need for genomic sequencing...</description>
                    <pubdate>1785876000000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>ACC Featured Jobs For August 2026</title>
<link>/Latest-in-Cardiology/Articles/2022/01/01/01/01/ACC-Featured-Jobs</link>                    <description>Ready to explore a new professional opportunity? Browse the list below of featured jobs and take the next step in your career!</description>
                    <pubdate>1785581280000</pubdate>
                    <category>Articles and Stories</category>
                </item>

    </channel>
</rss>